Cargando…
A potent, broadly protective vaccine against SARS-CoV-2 variants of concern
Since the first outbreak in December 2019, SARS-CoV-2 has been constantly evolving and five variants have been classified as Variant of Concern (VOC) by the World Health Organization (WHO). These VOCs were found to enhance transmission and/or decrease neutralization capabilities of monoclonal antibo...
Autores principales: | Wang, Ziyan, An, Jiao, Liu, Kunpeng, Yu, Pin, Fang, Xin, Li, Jiadai, Zhu, Hua, Zhu, Qianjun, Huang, Chuanqi, Zhang, Chao, Zhao, Binbin, Bao, Linlin, Song, Yujiao, Cao, Xiayao, Hu, Dongdong, Jiang, Yuanxiang, Shi, Likang, Zhou, Lingyun, Fan, Jiang, Guan, Wuxiang, Zhou, Chenliang, Hu, Zhongyu, Yuan, Zhiming, Liu, Jiangning, Shan, Chao, Liu, Ge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653380/ https://www.ncbi.nlm.nih.gov/pubmed/36371432 http://dx.doi.org/10.1038/s41541-022-00571-0 |
Ejemplares similares
-
Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants
por: Liu, Haitao, et al.
Publicado: (2021) -
Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis‐related genes
por: Diao, Xiayao, et al.
Publicado: (2021) -
PD‐1/PD‐L1 co‐location: A novel biomarker for immunotherapy response in non‐small cell lung cancer
por: Diao, Xiayao, et al.
Publicado: (2022) -
Construction of a Novel Prognostic Signature in Lung Adenocarcinoma Based on Necroptosis-Related lncRNAs
por: Diao, Xiayao, et al.
Publicado: (2022) -
Lymphatic metastasis in non‐small cell lung cancer: recent discoveries and novel therapeutic targets
por: Diao, Xiayao, et al.
Publicado: (2022)